Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia

被引:27
作者
Neuman, Mark I.
Kelley, Meera
Harper, Marvin B.
File, Thomas M., Jr.
Camargo, Carlos A., Jr.
机构
[1] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA
[2] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA
[3] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA
[4] Northeastern Ohio Univ Coll Med & Pharm, Rootstown, OH 44272 USA
[5] Summa Hlth Syst, Infect Dis Serv, Akron, OH USA
[6] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
关键词
Streptococcus pneumoniae; antibiotic resistance; mortality; bacteremia;
D O I
10.1016/j.jemermed.2006.08.014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We conducted a multicenter, retrospective cohort study of patients with Streptococcus pneumoniae bacteremia to determine factors associated with antibiotic resistance and mortality. Risk factors were identified using multivariate logistic regression. There were 1574 patients at 34 sites enrolled. Compared to isolates from patients not receiving an antibiotic before the index blood culture, patients receiving an antibiotic were less likely to harbor an antibiotic susceptible organism. Susceptibility to penicillin decreased from 78% (95% confidence interval [CI] 75-80) to 49% (95% CI 39-59); to cefotaxime/ceftriaxone, from 92% (95% CI 90-93) to 82% (95% CI 72-89); and to macrolide, from 84% (95% CI 82-87) to 55% (95% CI 41-68). Factors associated with macrolide non-susceptibility include: > 24 h of antibiotic therapy at time of the index culture (odds ratio [OR] 4.0), residing in southern U.S. (OR 1.7), and having an antibiotic allergy (OR 1.7). Harboring an antibiotic non-susceptible strain (OR 1.4) and male sex (OR 1.4) were associated with increased risk of mortality, whereas black race (OR 0.6) and evidence of focal infection (OR 0.6) were associated with decreased risk. (c) 2007 Elsevier Inc.
引用
收藏
页码:349 / 357
页数:9
相关论文
共 26 条
[1]   Reevaluation of outpatients with Streptococcus pneumoniae bacteremia [J].
Bachur, R ;
Harper, MB .
PEDIATRICS, 2000, 105 (03) :502-509
[2]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[3]  
*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P800
[4]  
Centers for Disease Control and Prevention, 2000, ACT BACT COR SURV RE
[5]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[6]   Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin [J].
Fogarty, C ;
Goldschmidt, R ;
Bush, K .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :613-615
[7]   Low dosage and long treatment duration of β-lactam -: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae [J].
Guillemot, D ;
Carbon, C ;
Balkau, B ;
Geslin, P ;
Lecoeur, H ;
Vauzelle-Kervroëdan, F ;
Bouvenot, G ;
Eschwége, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05) :365-370
[8]   EFFECT OF ANTIBIOTIC-THERAPY ON THE OUTCOME OF OUTPATIENTS WITH UNSUSPECTED BACTEREMIA [J].
HARPER, MB ;
BACHUR, R ;
FLEISHER, GR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (09) :760-767
[9]   Management of community-acquired pneumonia in the era of pneumococcal resistance -: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group [J].
Heffelfinger, JD ;
Dowell, SF ;
Jorgensen, JH ;
Klugman, KP ;
Mabry, LR ;
Musher, DM ;
Plouffe, JF ;
Rakowsky, A ;
Schuchat, A ;
Whitney, CG .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) :1399-1408
[10]   National Department of Defense Surveillance for invasive Streptococcus pneumoniae:: Antibiotic resistance, serotype distribution, and arbitrarily primed polymerase chain reaction analyses [J].
Hudspeth, MK ;
Smith, TC ;
Barrozo, CP ;
Hawksworth, AW ;
Ryan, MAK ;
Gray, GC .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (05) :591-596